Production of [89Zr]Oxinate4 and cell radiolabeling for human use
- 16 December 2020
- journal article
- research article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 64 (5) , 209-216
Abstract
[89Zr]Oxinate4 is a Positron Emission Tomography (PET) tracer for cell radiolabeling that can enable imaging techniques to help better understand cell trafficking in various diseases. Although several groups have synthetized this compound for use in preclinical studies, there is no available data regarding the production of [89Zr]Oxinate4 for human use. In this report, we describe the detailed production of [89Zr]Oxinate4 under USP and autologous leukocyte radiolabeling under USP . The final product presented high radiochemical purity and stability at 24 h post synthesis (>99%) and passed in all quality control assays required for clinical use. [89Zr]Oxinate4 did not compromise the white blood cells viability and did not show considerable cellular efflux up to 3 h post labeling. The translation of this technique into human use can provide insight into several disease mechanisms since [89Zr]Oxinate4 has the potential to label any cell subset of interest.Keywords
This publication has 15 references indexed in Scilit:
- Production of Zr-89 using sputtered yttrium coin targetsNuclear Medicine and Biology, 2017
- Bone Marrow Cell Trafficking Analyzed by 89Zr-oxine Positron Emission Tomography in a Murine Transplantation ModelClinical Cancer Research, 2017
- 89Zr-Oxine Complex PET Cell Imaging in Monitoring Cell-based TherapiesRadiology, 2015
- [89Zr]Oxinate4 for long-term in vivo cell tracking by positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Synthesis and characterisation of zirconium complexes for cell tracking with Zr-89 by positron emission tomographyDalton Transactions, 2014
- Routine Production of 89Zr Using an Automated ModuleApplied Sciences, 2013
- Guidelines for the labelling of leucocytes with 111In-oxineEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Radiopharmaceuticals for the study of 4 inflammatory processesNuclear Medicine Communications, 1997
- Imaging of inflammatory processes with labeled cellsSeminars in Nuclear Medicine, 1984
- Preparation and Evaluation of111In-Labeled Leukocytes as an Abscess Imaging Agent in DogsRadiology, 1976